+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antigen Presenting Cell"

Gastric Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Gastric Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 550 Pages
  • Global
From
Peritoneal cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Peritoneal cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 220 Pages
  • Global
From
Esophageal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Esophageal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Acute Graft-versus-Host Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Graft-versus-Host Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Graft versus host disease - Pipeline Insight, 2024 - Product Thumbnail Image

Graft versus host disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 220 Pages
  • Global
From
Toll-Like Receptor 8 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Toll-Like Receptor 8 Agonist - Pipeline Insight, 2024

  • Drug Pipelines
  • March 2024
  • 60 Pages
  • Global
From
4-1BB receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

4-1BB receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
Anti-CD40 Antibody - Pipeline Insight, 2024 - Product Thumbnail Image

Anti-CD40 Antibody - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2024 - Product Thumbnail Image

T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
From
Natural Killer Cell Therapies: Pipeline Review - Product Thumbnail Image

Natural Killer Cell Therapies: Pipeline Review

  • Report
  • June 2019
  • 80 Pages
  • Global
From
From
Monoclonal antibodies - Competitive landscape, 2023 - Product Thumbnail Image

Monoclonal antibodies - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
CTLA-4 inhibitors- Competitive landscape, 2023 - Product Thumbnail Image

CTLA-4 inhibitors- Competitive landscape, 2023

  • Report
  • May 2023
  • 220 Pages
  • Global
From
From
Tecentriq (atezolizumab; Roche/Chugai) Drug Overview 2019 - Product Thumbnail Image

Tecentriq (atezolizumab; Roche/Chugai) Drug Overview 2019

  • Drug Pipelines
  • September 2019
  • 114 Pages
  • Global
Tyrosine Protein Kinase ITK/TSK - Pipeline Review, H1 2020 - Product Thumbnail Image

Tyrosine Protein Kinase ITK/TSK - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 66 Pages
  • Global
From
Loading Indicator

The Antigen Presenting Cell (APC) market is a subset of the Immune Disorders Drugs market. APCs are specialized cells that play a key role in the immune system by recognizing and presenting antigens to other cells of the immune system. APCs are used in the development of drugs for a variety of immune disorders, including autoimmune diseases, allergies, and cancer. APCs are also used in the development of vaccines, as they are able to recognize and present antigens to the immune system, triggering an immune response. The APC market is expected to grow in the coming years, driven by the increasing prevalence of immune disorders and the development of new treatments. Additionally, the increasing demand for personalized medicine is expected to drive the growth of the APC market. Some companies in the APC market include Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, and Miltenyi Biotec. Show Less Read more